Patent ID: 9206167
Filing Date: 2015-12-08
Classification: A61K,A61P,C07D

Abstract:
1. A method for treating bipolar I type disorder, bipolar II type disorder comprising administering a heterocyclic compound represented by the formula (I) or a salt thereof to a human or animal: wherein ring Q represented by represents wherein represents —NH—CH between the 3-position and 4-position of the heterocyclic skeleton containing Z and Y represents a single bond or a double bond; the ring Q may have at least one substituent selected from the group consisting of a lower alkyl group, a lower alkenyl group, a lower alkynyl group, a hydroxy group, a lower alkoxy group, a halogenated lower alkyl group, an aryl group, an aryl lower alkyl group, an aryl lower alkoxy group, an arylcarbonyl group, a lower alkenyloxy group, a lower alkanoyl group, a lower alkanoyloxy group, a cycloalkyl group, a cycloalkyl lower alkyl group, a halogen atom, a carbamoyl group which may have a lower alkyl group, a carboxy group, a lower alkoxycarbonyl group, an amino group which may have a lower alkanoyl group, a nitro group, a hydroxy lower alkyl group, an amino lower alkyl group which may have a lower alkyl group, a thienyl group, a saturated 3- to 8-membered heteromonocyclic group containing 1 to 2 nitrogen atoms-substituted lower alkyl group and an oxo group; R A represents —O-A provided that when A represents a lower alkylene group, the ring Q represents a bicyclic group selected from the group consisting of: wherein the carbon-carbon-bond   represents a single bond or a double bond.